Broader criteria of undifferentiated connective tissue disease in idiopathic interstitial pneumonias

Respiratory Medicine

Volumn 109, Issue 3, 2015, Pages 389-396

  Kondoh, Yasuhiro ^a   Johkoh, Takeshi ^b   Fukuoka, Junya ^c   Arakawa, Hiroaki ^d   Tanaka, Tomonori ^c   Watanabe, Naohiro ^e   Sakamoto, Koji ^e   Kataoka, Kensuke ^a   Kimura, Tomoki ^a   Taniguchi, Hiroyuki ^a  

^a TOSEI GENERAL HOSPITAL   (Japan)

^b Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^c NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^d DOKKYO MEDICAL UNIVERSITY   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Idiopathic interstitial pneumonias; Idiopathic pulmonary fibrosis; IIPs ; IPF ; Nonspecific interstitial pneumonia; NSIP ; SLB ; Surgical lung biopsy; Uctd undifferentiated connective tissue disease

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLOSPORIN A; IMMUNOGLOBULIN G; PIRFENIDONE; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CHECKLIST; CHRONIC RESPIRATORY FAILURE; CLINICAL EVALUATION; CLINICAL RESEARCH; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DESCRIPTIVE RESEARCH; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; FORCED VITAL CAPACITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEROLOGY; SURVIVAL; SURVIVAL RATE; THORAX RADIOGRAPHY; UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE; AGED; BIOPSY; COMPARATIVE STUDY; COMPLICATION; CONNECTIVE TISSUE DISEASES; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGY; FORCED EXPIRATORY VOLUME; IDIOPATHIC INTERSTITIAL PNEUMONIAS; IDIOPATHIC PULMONARY FIBROSIS; JAPAN; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPIROMETRY;

AGED; BIOPSY; CONNECTIVE TISSUE DISEASES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; IDIOPATHIC PULMONARY FIBROSIS; JAPAN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84933179089     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.01.009     Document Type: Article

References (25)

1. Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, Jones KD, King Jr TE. Idiopathic nonspecific interstitial pneumonia. Am J Respir Crit Care Med 2007;176:691-7.
2. Kinder BW, Shariat C, Collard HR, Koth LL, Wolters PJ, Golden JA, Panos RJ, King Jr TE. Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung 2010;188:143e9.
3. Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002;165:1581-6.
4. Flaherty KR, Colby TV, Travis WD, Toews GB, Mumford J, Murray S, Thannickal VJ, Kazerooni EA, Gross BH, Lynch 3rd JP, Martinez FJ. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 2003;167:1410-5.
5. Song JW, Do KH, Kim MY, Jang SJ, Colby TV, Kim DS. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 2009;136:23-30.
6. Corte TJ, Copley SJ, Desai SR, Zappala CJ, Hansell DM, Nicholson AG, Colby TV, Renzoni E, Maher TM, Wells AU. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012;39:661e8.
7. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King Jr TE, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ. ATS/ERS/JRS/ALAT Committee on idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
8. Travis WD, Costabel U, Hansell DM, King Jr TE, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, Behr J, Bouros D, Brown KK, Colby TV, Collard HR, Cordeiro CR, Cottin V, Crestani B, Drent M, Dudden RF, Egan J, Flaherty K, Hogaboam C, Inoue Y, Johkoh T, Kim DS, Kitaichi M, Loyd J, Martinez FJ, Myers J, Protzko S, Raghu G, Richeldi L, Sverzellati N, Swigris J, Valeyre D. ATS/ERS committee on idiopathic interstitial pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733-48.
9. Kondoh Y, Kimura T, Taniguchi H, Johkoh T, Fujimoto K, Arakawa H, Sumikawa H, Tanaka T, Fukuoka J. Prospective study of utility of undifferentiated connective tissue disease for a diagnosis of idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2012;185:A6603.
10. Medical Section of the American Lung Association. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
11. Hanamoto S, Ohsuji T, Tsuyaguchi I, Kawabata S, Kimura K. Prediction formulas for pulmonary function tests expressed in linear and exponential form for healthy Japanese adults. Nihon Kyobu Shikkan Gakkai Zasshi 1992;30:2051-60.
12. American Thoracic Society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
13. Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King Jr TE, Wolters PJ, Collard HR. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J 2013;42:750-7.
14. Mosca M, Neri R, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 1999;17:615-20.
15. Vij R, Noth I, Strek ME. Autoimmune-featured interstitial lung disease: a distinct entity. Chest 2011;140:1292e9.
16. Latsi PI, du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou A, Veeraraghavan S, Hansell DM, Wells AU. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003;168:531-7.
17. Collard HR, King Jr TE, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168:538-42.
18. Flaherty KR, Mumford JA, Murray S, Kazerooni EA, Gross BH, Colby TV, Travis WD, Flint A, Toews GB, Lynch 3rd JP, Martinez FJ. Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168:543-8.
19. Jegal Y, Kim DS, Shim TS, Lim CM, Do Lee S, Koh Y, Kim WS, Kim WD, Lee JS, Travis WD, Kitaichi M, Colby TV. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005;171:639-44.
20. Taniguchi H, Ebina M, Kondoh Y, Ogura T, Azuma A, Suga M, Taguchi Y, Takahashi H, Nakata K, Sato A, Takeuchi M, Raghu G, Kudoh S, Nukiwa T. Pirfenidone clinical study group in Japan. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2010;35:821-9.
21. Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King Jr TE, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM, CAPACITY Study Group. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011;377:1760-9.
22. Lee JS, Kim EJ, Lynch KL, Elicker B, Ryerson CJ, Katsumoto TR, Shum AK, Wolters PJ, Cerri S, Richeldi L, Jones KD, King Jr TE, Collard HR. Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis. Respir Med 2013;107:249-55.
23. Fischer A, West SG, Swigris JJ, Brown KK, du Bois RM. Connective tissue disease-associated interstitial lung disease. A call for clarification. Chest 2010;138:251-6.
24. Fischer A, Brown KK. Interstitial lung disease in undifferentiated forms of connective tissue disease. Arthritis Care Res Hob 2015;67:4-11.
25. Cottin V. Significance of connective tissue diseases features in pulmonary fibrosis. Eur Respir Rev 2013;22:273-80.